Table 2.
Clinical and medication characteristics of study participants in the Amhara region public hospitals (2010–2016)
| Variable | Category | Number | % |
|---|---|---|---|
| Regimen type | d4T + 3TC + NVP | 327 | 34.3 |
| d4T + 3TC + EFV | 76 | 8.0 | |
| AZT + 3TC + NVP | 333 | 34.9 | |
| AZT + 3TC + EFV | 160 | 16.8 | |
| Others | 55 | 5.8 | |
| Functional status | Working | 323 | 33.9 |
| Ambulatory | 462 | 48.4 | |
| Bedridden | 166 | 17.5 | |
| BWHO stage | Stage I | 286 | 29.9 |
| Stage II | 309 | 32.4 | |
| Stage III | 287 | 30.1 | |
| Stage IV | 69 | 7.2 | |
| Disclosure | Yes | 720 | 75.7 |
| No | 231 | 24.3 | |
| Opportunistic infection | Yes | 691 | 72.7 |
| No | 260 | 27.3 | |
| MARV status | Yes | 909 | 95.6 |
| No | 42 | 4.4 | |
| Medication adherence | Poor | 291 | 38.04 |
| Fair | 117 | 15.29 | |
| Good | 357 | 46.67 |
BWHO baseline WHO stage, MARV mothers’ antiretroviral